Oncotarget Quizartinib, a selective FLT3 inhibitor, maintains antileukemic activity
Oncotarget Volume 11, Issue 11 reported that in this preclinical study, we characterized the binding affinity and selectivity of quizartinib, a small-molecule inhibitor of FLT3,...















